Glioblastoma - therapy - quality of life
Glioblastoma [brain tumor]:
is the most common malignant brain tumor in adults. If possible, an attempt is made to surgically remove the tumor or to reduce the tumor mass. The average survival time is 15 months and cannot be cured with conventional medical treatment methods. Chemotherapy often does not work because the cytostatics cannot cross the blood-brain barrier. Radiation is often used as a therapeutic measure, but it can also be a painful procedure for most of those affected. (scalp burns, etc.)
In studies at 80 locations and 4 countries including the USA, Canada, Germany and England on patients aged 18 to 78 years with a diagnosis of glioblastoma, autologous dendritic cell therapy was carried out in addition to standard therapeutic measures such as surgery, chemotherapy and radiotherapy. Survival and quality of life consistently improved in 223 patients who participated in the phase 3 study. The survival rate beyond 40.5 years was over 80%.
Immunotherapy is a promising therapeutic measure that has little impact on maintaining quality of life. The serum in a tumor vaccination [eg dendritic cell therapy] overcomes the blood-brain barrier while fighting metastases at the same time. The effect of immunotherapy with "dendritic cells" has been proven in dozens of publications, dissertations and studies.
Free second/third opinion
Immunotherapy can help to fight the tumor and its metastases optimally and sustainably without impairing the quality of life. You can find out here free of charge whether the possibility of immunotherapy with antigen-presenting dendritic cells can also have a chance of successful therapy for your cancer. To do this, send us your most recent findings and blood values and you will receive a free report with 2 to 3 studies. You can then discuss this report with your/our doctor. If you have any questions, we are happy to help. Request the free report here. [link]